You are here

  • Home
  • Archive
  • Volume 26, Issue 1
  • Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial

Citation Tools

Article menu

Download PDFPDF

Gestational Trophoblastic Neoplasia
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
You B, Deng W, Hénin E, et al
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial
International Journal of Gynecologic Cancer 2016;26:208-215.